Austin Aerts Sells 7,179 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA) CFO Austin Aerts sold 7,179 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $7.32, for a total transaction of $52,550.28. Following the completion of the transaction, the chief financial officer now directly owns 291,486 shares of the company’s stock, valued at approximately $2,133,677.52. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Austin Aerts also recently made the following trade(s):

• On Tuesday, September 10th, Austin Aerts sold 5,056 shares of Sera Prognostics stock. The stock was sold at an average price of $7.57, for a total transaction of $38,273.92.

Sera Prognostics Stock Down 3.7 %

SERA opened at $6.97 on Thursday. The business’s fifty day simple moving average is $7.40 and its 200 day simple moving average is $7.65. Sera Prognostics, Inc. has a 52 week low of $1.65 and a 52 week high of $12.35. The stock has a market cap of $232.59 million, a PE ratio of -7.04 and a beta of 1.04.

Sera Prognostics (NASDAQ:SERA) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.24) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.02). The firm had revenue of $0.03 million during the quarter, compared to analysts’ expectations of $0.09 million. During the same quarter in the previous year, the business earned ($0.23) EPS. As a group, equities analysts anticipate that Sera Prognostics, Inc. will post -0.96 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. RA Capital Management L.P. bought a new stake in Sera Prognostics in the first quarter valued at approximately $18,420,000. AWM Investment Company Inc. raised its holdings in Sera Prognostics by 56.0% during the 1st quarter. AWM Investment Company Inc. now owns 584,664 shares of the company’s stock valued at $5,320,000 after buying an additional 209,762 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Sera Prognostics by 100.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 150,708 shares of the company’s stock valued at $892,000 after buying an additional 75,441 shares during the last quarter. Ballentine Partners LLC purchased a new stake in Sera Prognostics during the 2nd quarter valued at $294,000. Finally, Twelve Points Wealth Management LLC bought a new stake in Sera Prognostics in the 2nd quarter worth $257,000. 54.64% of the stock is owned by hedge funds and other institutional investors.

Sera Prognostics Company Profile

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.